scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.YPMED.2008.02.023 |
P698 | PubMed publication ID | 18456313 |
P2093 | author name string | S Czernichow | |
A-C Vergnaud | |||
S Hercberg | |||
P Galan | |||
S Bertrais | |||
P2860 | cites work | Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 |
Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study | Q24630111 | ||
Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey | Q28186036 | ||
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study | Q28281870 | ||
Mortality by cause for eight regions of the world: Global Burden of Disease Study | Q29615121 | ||
A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study | Q30713072 | ||
Prediction of first coronary events with the Framingham score: a systematic review | Q33282507 | ||
A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study--design, methods, and participant characteristics. SUpplementation en VItamin | Q34067086 | ||
The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals | Q34370181 | ||
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project | Q34534248 | ||
By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease | Q35771476 | ||
Cardiovascular disease risk assessment in older women: can we improve on Framingham? British Women's Heart and Health prospective cohort study. | Q35772030 | ||
Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study | Q36768750 | ||
21 year trends in incidence of myocardial infarction and mortality from coronary disease in middle-age | Q39435223 | ||
Use and misuse of the receiver operating characteristic curve in risk prediction | Q40241086 | ||
The Framingham prediction rule is not valid in a European population of treated hypertensive patients | Q44164785 | ||
Alcohol consumption and insulin resistance syndrome parameters: associations and evolutions in a longitudinal analysis of the French DESIR cohort | Q44808917 | ||
Updated risk factor values and the ability of the multivariable risk score to predict coronary heart disease | Q45026853 | ||
Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. | Q45230526 | ||
A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study | Q46530577 | ||
Inflammatory markers and long-term risk of ischemic heart disease in men A 13-year follow-up of the Quebec Cardiovascular Study | Q46700751 | ||
Trends and geographical disparities in coronary heart disease in France: are results concordant when different definitions of events are used? | Q50656460 | ||
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. | Q51922378 | ||
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paper. | Q51981696 | ||
Framingham risk function overestimates risk of coronary heart disease in men and women from Germany—results from the MONICA Augsburg and the PROCAM cohorts | Q52017724 | ||
Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. | Q52082107 | ||
An updated coronary risk profile. A statement for health professionals. | Q52461335 | ||
Estimation of CHD risk in a French working population using a modified Framingham model | Q56788609 | ||
Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study | Q57605872 | ||
Comparison of multivariate predictive power of major risk factors for coronary heart diseases in different countries: results from eight nations of the Seven Countries Study, 25-year follow-up | Q63283501 | ||
The seven countries study: 2,289 deaths in 15 years | Q71404923 | ||
The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe | Q74152265 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 61-65 | |
P577 | publication date | 2008-03-10 | |
P1433 | published in | Preventive Medicine | Q7242397 |
P1476 | title | Ten-year risk prediction in French men using the Framingham coronary score: results from the national SU.VI.MAX cohort | |
P478 | volume | 47 |
Q33691318 | A coronary heart disease prediction model: the Korean Heart Study. |
Q51227849 | External validation of the 2008 Framingham cardiovascular risk equation for CHD and stroke events in a European population of middle-aged men. The PRIME study. |
Q51583909 | Predicting CHD risk in France: a pooled analysis of the D.E.S.I.R., Three City, PRIME, and SU.VI.MAX studies. |
Q26772283 | Reassessing the Usefulness of Coronary Artery Calcium Score among Varying Racial and Ethnic Groups by Geographic Locations: Relevance of the Korea Initiatives on Coronary Artery Calcification Registry |
Q51759238 | SCORE should be preferred to Framingham to predict cardiovascular death in French population. |
Q39800987 | Ten-year risk of all-cause mortality: assessment of a risk prediction algorithm in a French general population |
Q59808811 | The challenge of asymptomatic coronary artery disease in aircrew; detecting plaque before the accident |
Search more.